Biosensor Market 2022
Biosensor Market Will Reach US $22.55 billion in 2022.
With growing incidences of chronic illnesses coupled with rising healthcare costs, there is a need for future health systems that would deliver more scalable, accessible, and equitable solutions, that too, while safeguarding the environment. As such, AI-based automation is the buzzword. Image-guided therapy can’t be imagined these days without the intervention of AI. Also, auto-logging various steps of minimally invasive procedures is on the anvil. Virtual collaborations are also seen amongst providers, thereby offering various poignant opportunities. This would be the scenario with healthcare electronics market in the near future.
Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/3589
According to a new market report published by Persistence Market Research “Global Market Study on Biosensor: Asia-Pacific to Witness Highest Growth by 2022,” the global biosensor market was valued at USD 12,963.6 million in 2014 and is expected to grow at a CAGR of 9.7% from 2014 to 2022, to reach an estimated value of USD 22,551.2 million in 2022.
Globally, the biosensors market is witnessing significant growth due to increasing demand of point of care testing. In addition, rising prevalence of chronic and lifestyle associated diseases, growing geriatric population, increasing application of biosensors in various industries and growing application of nanotechnology in healthcare are also driving the growth of the market.
In addition, emergence and demand of personalized medicine and non-invasive biosensors would also drive the growth for the market. However, strict regulatory requirements and reimbursement policy issues in healthcare system hamper growth of the global biosensors market. In addition, the regulatory process is not keeping pace with the rapid development of new medical technologies.
Some of the major players in the biosensors market:
- Abbott Laboratories, Inc.
- Siemens Healthcare.
- Nova Biomedical Corporation.
- Bayer AG.
- Johnson and Johnson.
- Medtronic, Inc.
- Hoffmann-La Roche, Ltd.
- Other.
In North America, growing aging population, increasing health awareness, rising chronic and lifestyle diseases, technological developments for various home use applications, and appropriate insurance coverage are driving the use of biosensor devices in the market.
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/3589
In Europe, the biosensors device market is driven by rising diagnostic requirements due to increasing lifestyle associated diseases, aging population and improving healthcare infrastructure. On the other hand, increasing healthcare costs has shifted the focus of healthcare from hospitals to home, which would increase the use of biosensors devices in the region.
However, Asia is becoming one of the most attractive markets for medical device companies. The growth for biosensor devices in Asia is much higher than developed countries due to widening health insurance penetration, large population base and up-gradation of health care systems.
The biosensors market is segmented as follows:
Biosensors market, by technology
- Electrochemical biosensors
- Optical biosensors
- Piezoelectric biosensors
- Thermistor biosensors
Biosensors market, by application
- Medical diagnostics
- Food toxicity detection
- Industrial process control
- Environmental
- Agricultural testing
Biosensors market, by end user
- Point-of-care testing
- Home healthcare diagnostics
- Research laboratories
- Security and bio-defense
Access Full Report@ https://www.persistencemarketresearch.com/checkout/3589
Key geographies evaluated in this report are:
North America – U.S, Canada
Europe – France, Germany, Italy, Spain, and the UK, Eastern Europe, CIS
APAC – China, India, Japan, Australia, Others
Latin America – Argentina, Brazil, Others
About us:
Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.
Contact us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – [email protected]